Announcements Trials
Browse Landscape

Phase

Phase 2/3 1Phase 2 1Phase 1 1

Status

Active not recruiting 4Recruiting 3Completed 3Withdrawn 1Not yet recruiting 1

Sponsor Class

OTHER 2NIH 1

Study Type

Interventional 3

Sponsor

Cancer Type

Head & Neck 3

Conditions

Head and Neck Neoplasms 41Squamous Cell Carcinoma of Head and Neck 37Prostatic Neoplasms 16Nasopharyngeal Carcinoma 12Carcinoma, Non-Small-Cell Lung 12Glioblastoma 11Uterine Cervical Neoplasms 10Gliosarcoma 10Brain Neoplasms 10Neoplasm Metastasis 9Carcinoma, Squamous Cell 8Breast Neoplasms 8Rectal Neoplasms 7Pancreatic Neoplasms 7Glioma 7Carcinoma 7Tongue Neoplasms 6Radiation Injuries 6Oropharyngeal Neoplasms 6Neoplasms 6Lung Neoplasms 6Astrocytoma 6Sarcoma 5Nasopharyngeal Neoplasms 5Papillomavirus Infections 4Endometrial Neoplasms 4Salivary Gland Neoplasms 3Oligodendroglioma 3Mouth Neoplasms 3Laryngeal Neoplasms 3

Interventions

Cisplatin 12Radiotherapy 10Cetuximab 9Fluorouracil 6Drug Therapy 5Docetaxel 5pembrolizumab 3Radiotherapy, Intensity-Modulated 3Radiation 3Laser Therapy 3Hydroxyurea 3sargramostim 2Surveys and Questionnaires 2Resistance Training 2Psychiatric Rehabilitation 2Nutritional Status 2Nicotine 2Counseling 2Celecoxib 2Carboplatin 2Bupropion 2Bronchoscopy 2sodium thiosulfate 1motexafin gadolinium 1gossypol acetic acid 1durvalumab 1adavosertib 1Zinc Oxide 1Varenicline 1Transcutaneous Electric Nerve Stimulation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Laryngeal Neoplasms × Radiotherapy, Intensity-Modulated × Clear all
NCT03258554 2026-06-02

Radiation Therapy With Durvalumab or Cetuximab in Treating Patients With Locoregionally Advanced Head and Neck Cancer Who Cannot Take Cisplatin

National Cancer Institute (NCI)

Phase 2/3 Completed
196 enrolled 31 charts
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Oropharyngeal Neoplasms

NCT02113878 2024-11-05

Phase Ib Study of BKM120 With Cisplatin and XRT in High Risk Locally Advanced Squamous Cell Cancer of Head and Neck

Dana-Farber Cancer Institute

Phase 1 Completed
23 enrolled 22 charts
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Nasopharyngeal Neoplasms

NCT00833261 2020-08-21

Nab-Paclitaxel, Cetuximab, Cisplatin, and Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer

University of Texas Southwestern Medical Center

Phase 2 Completed
37 enrolled 6 charts
Head & Neck

Carcinoma, Squamous Cell, Head and Neck Neoplasms, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Tongue Neoplasms, Carcinoma, Verrucous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡